(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses - Wikidata - awgldk - TriplyDB

(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses

(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses

http://www.wikidata.org/entity/Q37054790

about

Improved Cardiovascular Disease Outcomes in Older Adults Infiltrative Cardiomyopathies Update on treatment of light chain amyloidosis Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs Nuclear imaging modalities for cardiac amyloidosis Evolving landscape in the management of transthyretin amyloidosis Transthyretin Cardiac Amyloidosis in Older Americans.The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease.Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options.Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis.Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.An Isolated Case of Late-onset Amyloidogenic Transthyretin Type Familial Amyloid Polyneuropathy Associated with a Mutant Transthyretin Substituting Methionine for Valine at Position 30 Showing Latent Progressive Cardiac Involvement Confirmed by Seri Pathophysiology and treatment of cardiac amyloidosis.Nuclear imaging for cardiac amyloidosis.Role of non-invasive imaging in the work-up of cardiomyopathies.Cardiac amyloidosis: the great pretender.Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.Improving strategies for the diagnosis of cardiac amyloidosis.Novel strategies for the diagnosis and treatment of cardiac amyloidosis.Radionuclide Imaging Applications in Cardiomyopathies and Heart Failure.Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document: In collaboration with the 'Working Group on myocardial and pericardial diseases' of the European Society of Cardiology Endorsed by the Indian Academy of Echoc Recent Advances in Nuclear Cardiology Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.Recent advances in the noninvasive strategies of cardiac amyloidosis.Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.Role of Imaging in Evaluating Infiltrative Heart Disease.Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.Cardiac Amyloidosis: Diagnosis and Treatment Strategies.Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.Prognostic value of right ventricular systolic function in cardiac amyloidosis.Left ventricular deformation and torsion assessed by speckle-tracking echocardiography in patients with mutated transthyretin-associated cardiac amyloidosis and the effect of diflunisal on myocardial function.The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.How to image cardiac amyloidosis.Two types of amyloid in a single heart.

P2860

Q26766094-CC196DB8-F252-4802-8DF5-29E1FB318AF2 Q26798533-26A0B699-1B7F-49E5-85C4-157ACA88E94D Q26829735-64D41DB4-9C28-4114-8E50-58988978635F Q27009309-CD40D629-D292-49D9-91DE-86F062143DBA Q27024756-CE03C030-C3C8-4D44-8EDB-A5DEB63C38BA Q28086773-22B539EB-B567-45C3-BBB0-1A8C1CF1272E Q30244227-F26261BD-998D-4F16-B4C5-0E59D8461600 Q30847650-3E902A09-3CDE-410C-8243-9BE02B985518 Q33168881-9D07CC39-4278-4FFA-9CCC-428EA0A52717 Q34392552-FC3DA535-189E-4C4C-810F-9E98F0005FD0 Q34487487-95658F16-FDF4-4F2C-BE5B-9232DE9FE736 Q35949385-6C4A1C53-8D39-44EB-848B-5002C01E24AD Q36783800-BD58758C-9837-4CD0-A684-832E98ED297F Q37083158-1FA04DA4-7DE6-41DF-8EE3-FCA42B60030A Q37090794-C7F84B83-7D29-4263-ABE1-A2B6278C17A1 Q37681076-E74B4681-AACE-4630-B5EC-F73FB7C36CCB Q38259728-769466AD-631B-49C8-A7AC-AB1D6141EDEB Q38271439-6E51CFA7-6844-4A3D-A830-3BE11FA9EE3E Q38338232-3E852058-5EB0-48D3-91AD-8FB3D2E3FA96 Q38372860-99DDC779-0E86-4C51-81F4-04B0F10E9B89 Q38532386-1B26405D-EB8C-4B80-AC47-F60CF777558B Q38547033-651C9A46-84D5-48A0-BC38-ED7AA1C0458A Q38614967-FFA4194F-8707-467A-A979-7591E4DB53B3 Q38721841-3F5545EB-E44A-476B-B459-73F13DE7F0B7 Q38782767-B5659660-69A2-4880-B5D1-2C7AC2BFBFA9 Q38829878-73F689FC-F2FD-4FCB-A6D2-D8E327AE6277 Q38869625-E347F311-2DC8-47EF-B9C4-59D7E3A57D4B Q38935425-8155F3AF-BD57-4A5C-9830-ACC324FB24E7 Q38939270-EF7B5E9B-4721-4344-8050-D26B22947804 Q39095033-E4744487-4847-44C2-826B-0C47168BC061 Q39114674-7D19C194-B70C-433B-9897-EFD8224E908A Q39272596-B6AFD53E-F352-4D4E-9115-A7AE373A3480 Q39309126-EAE0B5E8-96FB-4897-B503-6D7D2D90FACF Q39320411-52B1D2A1-77F6-4FEA-A23C-CE2EAD40C61F Q39390119-07378DF4-7297-4A3A-9A31-C0DEF0D6686B Q40533944-4355B9A5-DA9B-4C3F-9513-F59EB0F037DB Q40963422-656E14A4-DC70-4969-8448-EA2E124C938C Q41693071-E03C23DF-B211-41D8-B9AC-DADEDF362206 Q41867190-E6F8F9C6-1315-48D5-9B3D-C63CACF80A17 Q42986387-76C6B7B6-72DB-49EE-AD97-11DCF5456E1E

P2860

(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses

http://www.wikidata.org/entity/Q37054790

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

(99m)Tc-pyrophosphate scintigr ...... and senile cardiac amyloidoses

@en

type

label

(99m)Tc-pyrophosphate scintigr ...... and senile cardiac amyloidoses

@en

prefLabel

(99m)Tc-pyrophosphate scintigr ...... and senile cardiac amyloidoses

@en

P1433

Q37054790-D14A0FA0-3EC9-492E-B47B-1A9E19FE7634

P1476

Q37054790-C97132B7-BDB9-4218-BFB4-C87997569CD3

P2093

Q37054790-0DA6B785-B9D5-4E9C-BE62-516D20266922

Q37054790-15166376-AA14-40E3-BDBB-F420C9E88643

Q37054790-85BFA80B-85FA-4FFC-936C-A07C38E6498F

Q37054790-A233C551-E69B-4C6D-8B78-292632512709

Q37054790-CC5BC269-00F6-4945-B973-7E5C0404B6E0

Q37054790-E5361AFF-A367-478E-8C22-433B4317F02B

P2860

Q37054790-055FED40-0E69-4078-8ECF-633068C72FD7

Q37054790-0B137D34-A010-4DC4-9A5D-2FB6209AD246

Q37054790-25980918-B9D9-4348-84F6-85C0D99F2114

Q37054790-2F6D1500-450C-4C17-8CB2-9FE42665F30D

Q37054790-3554CBF0-C052-4D9D-9743-514D616B0047

Q37054790-4CF9CFB6-B017-47CD-A41F-19ECD0C9983A

Q37054790-4F462E6B-533D-43DA-972F-BAA7B1E7E505

Q37054790-56C95867-3255-4718-BFCE-48AAA2CA6795

Q37054790-58FDF3CB-81D1-42E6-9EBE-AAA9A05981EB

Q37054790-621E0D59-6884-4D5D-BC3E-EB6324AD2E80

P304

Q37054790-3B658A95-A3FD-4642-B1CB-ADB3936FE872

P31

Q37054790-49C39F6F-156D-4A29-B0D4-E48B7CB03022

P356

Q37054790-B3B3B54C-78DE-493D-B293-8427CD7C9254

P433

Q37054790-5D2EDDAD-125D-4126-9022-1A818890E255

P478

Q37054790-B1EF5F22-DD96-49F4-8452-5E5BC829C4C9

P577

Q37054790-9D9E80DE-4021-4203-AADE-3C2207B36C52

P698

Q37054790-79E6115E-C511-42F9-B749-BC0536F03750

P932

Q37054790-E11A9859-90D7-4891-9DD2-F9AF2729974F

P356

CIRCIMAGING.112.000132

P1433

Circulation: Cardiovascular Imaging

P1476

(99m)Tc-pyrophosphate scintigr ...... and senile cardiac amyloidoses

@en

P2093

Adam Castaño

http://www.w3.org/2001/XMLSchema#string

Farhana Latif

http://www.w3.org/2001/XMLSchema#string

Mathew S Maurer

http://www.w3.org/2001/XMLSchema#string

Sabahat Bokhari

http://www.w3.org/2001/XMLSchema#string

Susan Deslisle

http://www.w3.org/2001/XMLSchema#string

Ted Pozniakoff

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of serum amyloid P-component (SAP) by amyloid fibrils

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.

Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.

Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.

Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology

Transthyretin cardiac amyloidoses in older North Americans.

Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.

Amyloid heart disease.

Transthyretin-related amyloidoses and the heart: a clinical overview.

P304

195-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCIMAGING.112.000132

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23400849

http://www.w3.org/2001/XMLSchema#string

P932

3727049

http://www.w3.org/2001/XMLSchema#string